日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Surrogate endpoints for survival in KEYNOTE-585: neoadjuvant/adjuvant pembrolizumab plus chemotherapy versus placebo plus chemotherapy for gastric or gastroesophageal junction adenocarcinoma

KEYNOTE-585研究中生存期的替代终点:新辅助/辅助帕博利珠单抗联合化疗与安慰剂联合化疗治疗胃癌或胃食管交界处腺癌的比较

Shitara, K; Bang, Y-J; Wyrwicz, L S; Rha, S Y; Oshima, T; Pietrantonio, F; Park, Y-K; Lonardi, S; Yañez, P; Yen, C-J; Metges, J-P; Garrido, M; Moehler, M; Pelles-Avraham, S; Yong, W P; Spallanzani, A; Jensen, E; Krishnan, R; Shih, C-S; Al-Batran, S-E

From consultation to choice: gynecologic cancer patients' perspectives on shared decision making in clinical practice - findings from a cross-sectional observational qualitative interview study

从咨询到选择:妇科癌症患者对临床实践中共同决策的看法——一项横断面观察性定性访谈研究的发现

Theis, S; Frühwein, H; Hasenburg, A; Moehler, M; Paul, N W

Patient needs in the context of gynecologic oncology and breast cancer: a validation study

妇科肿瘤和乳腺癌患者需求:一项验证性研究

Theis, Susanne; Frühwein, H; Hasenburg, A; Moehler, M; Paul, N W

European screening platform for EORTC clinical trials in advanced colorectal cancer 'SPECTAcolor'

欧洲晚期结直肠癌EORTC临床试验筛查平台“SPECTAcolor”

Folprecht, G; Morfouace, M; Collienne, M; Salazar, R; Stein, A; Elez, E; Wagner, A D; Arnold, D; Kohne, C H; Ducreux, M; Lordick, F; Borelli, B; Stevovic, A; Gorlia, T; Fontana, E; Aust, D; Golfinopoulos, V; Moehler, M; Tejpar, S

Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroups

免疫检查点抑制剂在晚期胃食管腺癌中的应用:不同程序性死亡配体1亚组的患者水平荟萃分析

Leone, A G; Mai, A S; Fong, K Y; Yap, D W T; Kato, K; Smyth, E; Moehler, M; Seong, J T C; Sundar, R; Zhao, J J; Pietrantonio, F

Advances in the management of hepatobiliary and pancreatic malignancies: highlights from the ESMO Annual Meeting 2023 by the EORTC GI Tract Cancer Group

欧洲癌症研究与治疗组织(EORTC)胃肠道肿瘤组在2023年欧洲肿瘤内科学会(ESMO)年会上发表的肝胆胰恶性肿瘤治疗进展亮点

Fulgenzi, C; Garajová, I; Moehler, M; Lutz, M P; Smyth, E; Rimassa, L; Neuzillet, C; Lamarca, A

EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol

欧洲癌症研究与治疗组织(EORTC)胃癌PD-L1生物标志物欧洲倡议:ASPIRE研究方案

Petrillo, A; Oudijk, L; Sundar, R; Daumer, C; Casas, J; D'Haese, D; Mauer, M; van Grieken, N; Smyth, E C; Moehler, M

A wind of change in upper gastrointestinal cancers: updates from ESMO 2023

上消化道肿瘤治疗领域迎来变革之风:ESMO 2023 最新进展

Cammarota, A; Siebenhüner, A R; Maqueda, M A; Fleitas-Kanonnikoff, T; van Laarhoven, H; de la Fouchardière, C; Obermannova, R; Moehler, M; Smyth, E C

Current practices and challenges in implementing precision medicine for upper gastrointestinal cancers in European academic centers: an EORTC survey

欧洲学术中心在实施上消化道癌症精准医疗方面的现状与挑战:一项欧洲癌症研究与治疗组织(EORTC)调查

Alsina, M; Huerta, A E; Lordick, F; Verschueren, S; Moehler, M; Fontana, E; Smyth, E; Sclafani, F; Wagner, A D; Rimassa, L; Lamarca, A; Neuzillet, C; Obermannová, R

Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis

错配修复缺陷、化疗与可切除胃癌患者的生存率:来自德国 staR 队列的观察性研究和荟萃分析

Stolze, T; Franke, S; Haybaeck, J; Moehler, M; Grimminger, P P; Lang, H; Roth, W; Gockel, I; Kreuser, N; Bläker, H; Wittekind, C; Lordick, F; Vieth, M; Veits, L; Waidmann, O; Lingohr, P; Peitz, U; Schildberg, C; Kruschewski, M; Vassos, N; Goni, E; Bruns, C J; Ridwelski, K; Wolff, S; Lippert, H; Schumacher, J; Malfertheiner, P; Venerito, M